Clinical Trial Update: Effects of Rec 0/0438 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Injury [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial updates for Rec 0/0438 in neurogenic detrusor overactivity due to spinal cord injury completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Detrusor Overactivity

Drugs mentioned

• Rec 0/0438

Snippet

Sponsor: RECORDATI GROUP | Conditions: Neurogenic Detrusor Overactivity | Phase 1, Phase 2 | Status: COMPLETED